Paul Buzinec
YOU?
Author Swipe
View article: Supplementary Figure 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Figure 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 60K, Appendix Figure A: Change in Median Procedure Cost between 2001 and 2006.
View article: Supplementary Table 2 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 2 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 59K, Appendix Table B: Procedures by Age Group.
View article: Supplementary Table 5 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 5 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 59K, Appendix Table E: Median (Mean SD) Cost Per Procedure in 2005 for HPV Vaccination Target Age Groups.
View article: Supplementary Figure 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Figure 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 60K, Appendix Figure A: Change in Median Procedure Cost between 2001 and 2006.
View article: Supplementary Table 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 69K, Appendix Table A: Codes Used to Identify Procedures.
View article: Supplementary Table 4 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 4 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 58K, Appendix Table D: Median (Mean SD) Cost Per Procedure, 2001-2006, by Age Group.
View article: Data from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Data from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
Background: Oncogenic types of human papillomavirus (HPV) have been linked to 99.7% of cervical cancer cases worldwide.Methods: This retrospective claims-based analysis was conducted to assess patterns of use and costs associated with diag…
View article: Supplementary Table 4 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 4 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 58K, Appendix Table D: Median (Mean SD) Cost Per Procedure, 2001-2006, by Age Group.
View article: Supplementary Table 3 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 3 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 12K, Appendix Table C: Procedure Rates Among Target Age Groups.
View article: Supplementary Table 5 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 5 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 59K, Appendix Table E: Median (Mean SD) Cost Per Procedure in 2005 for HPV Vaccination Target Age Groups.
View article: Supplementary Table 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 1 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 69K, Appendix Table A: Codes Used to Identify Procedures.
View article: Supplementary Table 3 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 3 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 12K, Appendix Table C: Procedure Rates Among Target Age Groups.
View article: Data from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Data from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
Background: Oncogenic types of human papillomavirus (HPV) have been linked to 99.7% of cervical cancer cases worldwide.Methods: This retrospective claims-based analysis was conducted to assess patterns of use and costs associated with diag…
View article: Supplementary Table 2 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Supplementary Table 2 from Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions Open
PDF file, 59K, Appendix Table B: Procedures by Age Group.
View article: Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database
Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database Open
Racial/ethnic minority patients with COVID-19 had more severe disease on initial presentation than White patients. Increased mortality risk was attenuated by hospitalization among Black patients but not Asian patients, indicating that outc…
View article: PS1338 TEMPORAL TRENDS IN TRANSFUSION BURDEN AMONG NEWLY DIAGNOSED PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A U.S. CLAIMS DATABASE STUDY
PS1338 TEMPORAL TRENDS IN TRANSFUSION BURDEN AMONG NEWLY DIAGNOSED PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A U.S. CLAIMS DATABASE STUDY Open
Background: Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematologic stem cell disorders characterized by ineffective hematopoiesis resulting in peripheral cytopenias. Anemia is the most prevalent of all cytopenias a…